Additional file 2: of Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors

Authors :: Shitara, Kohei
Taroh Satoh
Iwasa, Satoru
Kensei Yamaguchi
Muro, Kei
Komatsu, Yoshito
Nishina, Tomohiro
Esaki, Taito
Hasegawa, Jun
Kakurai, Yasuyuki
Kamiyama, Emi
Nakata, Tomoko
Nakamura, Kota
Sakaki, Hayato
Ichinosuke Hyodo
Publication Year :: 2019
Publisher :: figshare, 2019.
Abstract: Selection criteria: sufficient organ function (DOCX 13 kb)

Full Text Access

Tools